· Original article
Marvell credit facility doubles to $3 billion in new deal
Marvell credit facility doubles to $3 billion under an October 22 agreement, with no loans outstanding at inception and conditional room to expand.
FINANCEVELIX / News
Listed companies, earnings, corporate developments and equity markets. Company and asset tags identify the subjects of a story.
Choose topics to see up to three latest articles per topic in your account.
Your topic choices are private to your account. No email or push notifications.
Please wait…
Read the original source and publication date in each article.
Results: 3,883 · Page 174 / 324
· Original article
Marvell credit facility doubles to $3 billion under an October 22 agreement, with no loans outstanding at inception and conditional room to expand.
· Original article
Retail trading volumes are down 20% since summer and 45% since late 2025, Goldman Sachs says, even as household investment demand remains strong.
· Original article
Deutsche Bank's Roche upgrade raises its target to CHF 500 from CHF 340, as giredestrant trial results and upcoming FDA decisions frame the outlook.
· Original article
The Nordson acquisition of Swiss sensor maker Contrinex closed on October 23, 2026, at an enterprise value of approximately $168 million.
· Original article
Dr Reddy's earnings show a sequential margin recovery in September 2026, while management targets a November semaglutide supply restart.
· Original article
Himadri earnings show 58% Q2 FY27 revenue growth, but margin pressure and higher working capital accompany plans for new battery-material capacity.
· Original article
Wonder expansion plans include Texas openings in 2027, a paid restaurant-creation platform and kitchen automation as Marc Lore considers a future IPO.
· Original article
Indian IT bookings remained substantial in Q2 FY27, but longer contracts, implementation timelines and cost-conscious clients slowed revenue conversion.
· Original article
Polar LNG named Tim Talkington acting CEO of its operating company as it seeks US approval to buy an unfinished structure from Novatek.
· Original article
Rybrevant trial data show a 77% response rate in a 22-patient head and neck cancer subgroup, supporting further testing in an ongoing Phase 3 study.
· Original article
Brokerage profits rose in the September 2026 quarter as margin funding and other businesses helped offset weaker Indian equity trading activity.
· Original article
AT&T stock closed at $20.93 on October 23 as reported SpaceX cell-site talks drew attention, while tower owners rose and no signed lease was established.
Charts and market data by TradingView. Availability and delays vary by exchange.